GIAMPIETRO, Letizia
 Distribuzione geografica
Continente #
NA - Nord America 6.569
EU - Europa 3.922
AS - Asia 3.689
Continente sconosciuto - Info sul continente non disponibili 571
SA - Sud America 384
AF - Africa 69
OC - Oceania 4
Totale 15.208
Nazione #
US - Stati Uniti d'America 6.299
SG - Singapore 1.388
CN - Cina 1.009
IT - Italia 998
IE - Irlanda 463
TR - Turchia 449
UA - Ucraina 417
SE - Svezia 395
RU - Federazione Russa 337
GB - Regno Unito 330
VN - Vietnam 315
BR - Brasile 306
FR - Francia 290
IN - India 255
DE - Germania 224
CA - Canada 159
PL - Polonia 130
FI - Finlandia 118
HK - Hong Kong 56
ES - Italia 44
BD - Bangladesh 35
JP - Giappone 34
LT - Lituania 33
MX - Messico 33
AT - Austria 30
ZA - Sudafrica 24
BE - Belgio 23
CZ - Repubblica Ceca 23
NL - Olanda 23
PK - Pakistan 21
AR - Argentina 17
VE - Venezuela 16
KR - Corea 15
CR - Costa Rica 14
ID - Indonesia 14
IQ - Iraq 14
CO - Colombia 13
PH - Filippine 13
EC - Ecuador 12
HN - Honduras 12
CL - Cile 11
GT - Guatemala 11
IL - Israele 11
JM - Giamaica 10
SA - Arabia Saudita 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
CW - ???statistics.table.value.countryCode.CW??? 8
DZ - Algeria 8
MA - Marocco 8
GR - Grecia 7
PT - Portogallo 7
KE - Kenya 6
TW - Taiwan 6
CH - Svizzera 5
EE - Estonia 5
EG - Egitto 5
ET - Etiopia 5
HR - Croazia 5
MY - Malesia 5
PR - Porto Rico 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
IR - Iran 4
JO - Giordania 4
NI - Nicaragua 4
PE - Perù 4
SC - Seychelles 4
NP - Nepal 3
SV - El Salvador 3
YE - Yemen 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
GP - Guadalupe 2
LB - Libano 2
PA - Panama 2
PY - Paraguay 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BM - Bermuda 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
Totale 14.636
Città #
Singapore 1.052
San Jose 677
Chandler 591
Jacksonville 501
Ashburn 495
Dublin 455
Izmir 286
Beijing 255
Dearborn 243
Chieti 230
Dallas 229
Council Bluffs 196
Southend 196
Princeton 187
Nanjing 146
Los Angeles 141
Santa Clara 137
The Dalles 123
Ann Arbor 121
Ho Chi Minh City 110
Cambridge 103
Wilmington 94
Kraków 92
New York 82
Hanoi 69
Washington 68
Nanchang 67
Buffalo 62
Altamura 57
Tongling 56
North Bergen 53
Hong Kong 50
Houston 45
Boardman 44
São Paulo 41
Moscow 40
Munich 37
Atlanta 36
Rome 36
Hebei 35
Warsaw 34
Milan 33
Orem 33
Toronto 33
Brooklyn 32
Denver 32
Pescara 32
Teramo 32
Woodbridge 32
Tianjin 31
Jiaxing 30
Kocaeli 30
Kunming 30
Hefei 28
Helsinki 28
Bosa 27
Columbus 27
Montreal 27
Phoenix 27
Redondo Beach 27
Tokyo 27
Bologna 26
Shenyang 26
Jinan 25
Changsha 24
Ottawa 24
Brussels 23
Vienna 23
Chennai 21
Brno 20
Chicago 20
London 20
Poplar 19
Da Nang 18
Stockholm 18
Johannesburg 17
Frankfurt am Main 16
Haiphong 15
Hangzhou 15
Norwalk 15
Turku 15
Mount Pleasant 14
Ningbo 14
Mumbai 13
Augusta 12
League City 12
Mexico City 12
San Francisco 12
San José 12
Seattle 12
Amsterdam 11
Naples 11
Redwood City 11
Seoul 11
Ankara 10
Dong Ket 10
Nuremberg 10
Orange 10
Rio de Janeiro 10
Bari 9
Totale 8.786
Nome #
Anticancer Activity of Stilbene-Based Derivatives 208
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 205
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 204
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 198
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 195
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 190
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 189
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 188
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 185
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 184
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 184
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 183
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 182
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 180
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 178
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 177
Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies 176
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 175
Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview 174
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 173
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 170
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 170
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 169
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 169
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 168
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 167
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 165
Sintesi ed attività antibatterica di 3-cinnamoil e 3-piridinilossazolidin -2-oni 163
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 163
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 162
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 162
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 159
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 156
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 156
N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry 155
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 155
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 154
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 154
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 153
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 152
Synthesis and antiplatelet activity of clofibric acid analogues 150
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 150
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 149
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 148
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 146
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 146
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 146
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 145
Structural development studies of PPARs ligands based on tyrosine scaffold 145
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 143
Sintesi di analoghi chirali del gemfibrozil 2,5,disostituiti a potenziale attività antiaggregante piastrinica 142
PPAR-γ agonist GL516 reduces oxidative stress and apoptosis occurrence in a rat astrocyte cell line 142
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 140
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 140
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 139
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 136
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 135
Development of Fibrates as Important Scaffolds in Medicinal Chemistry 135
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 134
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 132
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 131
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 129
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 129
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 129
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 129
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 129
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 128
null 128
Synthetic strategies for lysine-proline chimeras: an overview 128
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 126
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 125
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 124
Synthesis and Biological Evaluation of Halogenated E-Stilbenols as Promising Antiaging Agents 124
PPARα as Potential Therapeutic Target for Neurodegenerative Diseases 124
Methods to Evaluate the Activity of Nitric Oxide Synthase 123
Effect of milrinone analogues on intracellular calcium increase in single living H9C2 cardiac cells 123
Synthesis, biological evaluation and molecular modelling of new PPARa agonists 122
Effect of milrinone analogues on intracellular calcium increase on single living H9C2 cells 122
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 122
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 121
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 121
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 120
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 120
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 120
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening 118
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 117
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 115
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 114
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 114
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 111
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 110
PPAR Ligands Containing Stilbene Scaffold 110
Stilbene derivatives as new perspective in antifungal medicinal chemistry 109
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 108
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 103
Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids 99
Synthesis, in vitro evaluation, and molecular modelling investigation of benzenesulfonimide Peroxisome Proliferator-Activated Receptors α antagonists 98
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 97
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 96
N-Acylsulfonylamides as a new class of PPARa antagonists 96
Totale 14.505
Categoria #
all - tutte 57.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022474 0 0 0 0 52 17 21 42 92 21 75 154
2022/20231.670 124 233 120 167 155 321 79 132 217 20 54 48
2023/2024771 61 32 58 21 49 231 193 10 7 27 6 76
2024/20251.894 72 341 338 46 38 94 73 97 174 99 256 266
2025/20264.301 338 154 394 574 517 263 783 271 424 346 178 59
2026/20271.312 107 195 228 548 234 0 0 0 0 0 0 0
Totale 15.208